A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer - Concepedia

Concepedia

Publication | Open Access

A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer

DOI Full Paper Access

11

Citations

11

References

2021

Year

Muhammad Saad Hamid, Lance K. Heilbrun, Jordan Maier, Kiran Devisetty, Irene Connolly, Isaac Kaufman, Kimberlee Dobson, Mackenzie K. Herroon, Daryn Smith, Sandra Sampson,

Advances in Radiation Oncology

Abstract

The combination was not well tolerated and does not warrant further investigation in men with intermediate- and high-risk prostate cancer.

References

	Year	Citations

Page 1